One limitation to the use of in vitro-produced embryos in cattle production systems is the fact that pregnancy rates after transfer to recipients are typically lower than when embryos produced in vivo are transferred. Conceptually, the oocyte and spermatozoon from which the embryo is derived could affect competence for post-transfer survival. There are sire differences in embryonic survival after transfer, but there is little evidence that an embryo's ability to establish pregnancy is determined by sex sorting of spermatozoa by flow cytometry. The role of the source of the oocyte as a determinant of embryonic survival after transfer has not been examined carefully. Conditions for embryo culture after fertilisation can have an impact on the ability of the embryo to establish pregnancy following transfer. Among the specific molecules produced in the reproductive tract of the cow that have been shown to improve competence of in vitro-produced embryos for post-transfer survival are colony-stimulating factor 2, insulin-like growth factor-1 (for recipients exposed to heat stress) and hyaluronan (for less-advanced embryos). There is also a report that embryo competence for post-transfer survival can be improved by inclusion of a carbon-activated air filtration system in the incubator used to culture embryos. Progress in developing culture systems to improve embryonic competence for survival after transfer would be hastened by the development of in vitro assays that accurately predict the potential of an embryo to establish pregnancy after transfer. A group of 52 genes has been identified that are differentially expressed in embryos that developed to term v. embryos that did not establish pregnancy. Perhaps a gene microarray consisting of these genes, alone or in combination with other genes, could be used to screen embryos for competence to establish pregnancy.
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Limitations in the competence of the transferred embryo to develop to term
All else being equal, pregnancy rates following transfer of a blastocyst-stage embryo into a recipient female should be higher than those achieved following insemination. This is because embryo transfer bypasses pregnancy failure caused by defects in the oocyte, ovulation, fertilisation and early embryonic development. Nonetheless, except in cases where fertility is very poor, for example during heat stress (Putney et al. 1989; Ambrose et al. 1999; Al-Katanani et al. 2002a; Rodrigues et al. 2004) , pregnancy rates following embryo transfer are typically no greater than after AI (Rodrigues et al. 2004; Block et al. 2005; Sartori et al. 2006) . It can be inferred from these observations that inefficiencies in the production, selection and transfer of embryos limit the transferred embryo's ability to establish and maintain pregnancy.
Competence for post-transfer survival can be a special problem for embryos produced in vitro. Pregnancy rates following transfer of a fresh embryo are often lower for cows receiving an in vitro-produced embryo than for cows receiving an embryo produced by superovulation (Farin et al. 1999; Hasler et al. 2003; Xu et al. 2006; Lonergan et al. 2007; Pontes et al. 2009 ). Moreover, embryos produced in vitro often survive cryopreservation very poorly (Ambrose et al. 1999; Enright et al. 2000; Al-Katanani et al. 2002a; Rizos et al. 2002a) . The production of embryos in vitro can also be associated with changes in gene expression (Lazzari et al. 2002; Rizos et al. 2002b) , imprinting defects (Suzuki et al. 2009 ) and an array of fetal abnormalities, including increased rates of abortion, fetal overgrowth and altered metabolism (Lazzari et al. 2002; Farin et al. 2006) .
Realisation of the full potential that embryo transfer represents for genetic selection, fertility enhancement and crossbreeding (Hansen and Block 2004) will depend on improvements in the potential of the in vitro-produced embryo to become a healthy calf after transfer to a recipient animal. Much of the research focus to improve in vitro production (IVP) of bovine embryos is based on end-points that estimate the yield of blastocysts rather than on the competence of embryos to survive after transfer. Although the yield of transferable embryos is an important criterion, changes in culture systems that improve the proportion of oocytes that become blastocysts may not necessarily result in embryos with a higher competence for post-transfer survival. In the present review, attention is focused on systems and technologies that have been evaluated by transferring embryos into recipient cattle.
Oocytes and spermatozoa as determinants of embryo competence for post-transfer survival
The fate of the embryo is already determined to some extent at the moment of fertilisation because of the genetic and nongenetic contributions the embryo receives from the gametes from which it was formed. Allelic variants of STAT5A and FGF2 have been identified that affect embryonic survival in vitro (Khatib et al. 2008a (Khatib et al. , 2008b and there are undoubtedly other genes that affect development. Most of the non-nuclear material of the zygote is derived from the oocyte, although the spermatozoon contributes the centriole used for the first cleavage division (Sutovsky and Schatten 1999) and some mRNA, the importance of which has not yet been defined (Ostermeier et al. 2004) . In addition, delays in fertilisation caused by dysfunctional spermatozoa could conceivably lead to oocyte aging and the formation of a defective embryo. Aged oocytes have been linked to asynchrony in pronuclear formation in humans (Goud et al. 1999) , changes in methylation patterns of maternally imprinted genes in mice (Liang et al. 2008) and reduced likelihood of development to the blastocyst stage in cattle (Park et al. 2005; Agung et al. 2006) .
Oocytes
There are large differences between oocytes in terms of competence to be fertilised and for the resultant embryo to develop to the blastocyst stage. Among the factors implicated in reduced oocyte competence in vitro are low body condition score (Snijders et al. 2000) , heat stress (Rocha et al. 1998; Zeron et al. 2001; Al-Katanani et al. 2002b) , feeding of a low-fat (FouladiNashta et al. 2007) or high-starch (Rooke et al. 2009 ) diet, high concentrations of plasma urea nitrogen (Santos et al. 2009) and, in some (Fouladi-Nashta et al. 2007) but not all (Snijders et al. 2000; Roth et al. 2008 ) studies, high milk yield. Blastocyst yield has also been reported to be higher in oocytes with low levels of glucose-6 phosphate dehydrogenase (Torner et al. 2008) and those that are darker in colour (related to increased lipid content and mitochondria; Jeong et al. 2009 ). In addition, conditions for maturation can affect resultant blastocyst yield and characteristics. Examples include duration of maturation (Park et al. 2005; Agung et al. 2006) , oxygen content of the gas phase (Mingoti et al. 2009 ) and the presence of serum (Korhonen et al. 2009 ), growth hormone (Izadyar et al. 1996) and leptin (Paula-Lopes et al. 2007) .
Despite the large variability in oocyte competence for maturation, fertilisation and development, it is not known whether competence of the embryo to survive after transfer is dependent upon the oocyte from which it was derived. The study by Park et al. (2005) illustrates the potential for oocyte source to be a determinant of embryo competence for post-transfer survival. In that study, oocytes were matured for either 18 or 24 h before insemination. Although cleavage rate was not affected, a greater proportion of oocytes matured for 18 h became blastocysts following insemination than did oocytes matured for 24 h. In addition, blastocyst cell number was greater for the 18-h group and there was a non-significant tendency for pregnancy rate after the transfer of embryos to be greater for blastocysts derived from oocytes matured for 18 h than from those matured for 24 h (Table 1) .
Spermatozoa
The sire used for IVF can affect the ability of the resultant embryos to develop to the blastocyst stage and to establish pregnancy after transfer. Palma and Sinowatz (2004) observed differences in blastocyst yield among sires used for IVF. Although not calculated by the authors, inspection of the data reveals that embryo competence for development, calculated as the proportion of cleaved embryos that become blastocysts, also varied between bulls. For example, among a group of five bulls, the proportion of cleaved embryos becoming blastocysts ranged from 32% to 45%. Similar results have been reported by Xu et al. (2006) . As indicated in Table 1 , sire effects persist into the post-transfer period because the pregnancy rate in recipients of embryos produced by fertilisation with sex-sorted spermatozoa differed significantly among sires (Wilson et al. 2005) .
Damage to the spermatozoa after ejaculation can lead not only to a reduced fertilisation rate, but also to the formation of embryos with reduced ability to develop to the blastocyst stage. This phenomenon has been demonstrated for embryos formed from spermatozoa exposed to gossypol (Brocas et al. 1997) , oxidative stress (Silva et al. 2007 ) and sorting for gender by flow cytometry (Lu et al. 1999; Wheeler et al. 2006; Wilson et al. 2006; Morton et al. 2007) . Embryos produced by sex-sorted spermatozoa have also been shown to have altered steady state levels of specific mRNA (Morton et al. 2007) . Nonetheless, there is little evidence to indicate that blastocysts formed after fertilisation with damaged spermatozoa have reduced competence to establish pregnancies after transfer to recipients. In a large-scale study using embryos produced with sexed-sorted spermatozoa, Xu et al. (2006) found that the pregnancy rate at 70 days gestation was 41.9% (n = 3627 recipients) for females receiving embryos produced with sex-sorted spermatozoa compared with 40.9% (n = 481) for females receiving embryos produced with non-sorted spermatozoa.
Importance of the preimplantation period for embryo competence
In vivo, development is played out in the female reproductive tract. The maternal environment affects embryonic development by providing an array of nutrients to the embryo, expression of cell adhesion molecules that facilitate eventual attachment and placentation and the secretion of regulatory molecules that modulate embryonic development (Spencer et al. 2008) . There is no absolute requirement of the embryo for macromolecules specific to the reproductive tract environment because embryos can be produced in vitro and give rise to live calves after transfer to recipients. However, as detailed at the beginning of this review, embryos produced by in vitro oocyte maturation, fertilisation and culture have aberrant biochemical and molecular properties compared with embryos produced in vivo, as well as reduced survival after transfer into recipients than embryos produced in vivo.
Deviation in embryonic function associated with production in vitro is due, in part, to an inadequate culture environment during the embryonic period. This conclusion is based on observations that placement of embryos produced in vitro in the sheep oviduct after fertilisation resulted in blastocysts with gene expression patterns and cryotolerance that was more similar to that for blastocysts produced in vivo than in vitro-produced embryos that were cultured after fertilisation (Rizos et al. 2002a (Rizos et al. , 2002b . Several specific molecules produced in the reproductive tract of the cow have been shown to improve embryo competence for post-transfer survival. These are detailed below.
Colony-stimulating factor 2
Also called granulocyte-macrophage colony-stimulating factor, colony-stimulating factor 2 (CSF2) is present in both the oviduct and endometrium of the cow throughout the oestrous cycle, with greatest expression in epithelial cells (de Moraes et al. 1999; Emond et al. 2004) . Immunoreactive CSF2 in the endometrium was higher from Day 18 to Day 30 of pregnancy than at earlier stages of pregnancy or the oestrous cycle (Emond et al. 2004) . Expression of CSF2 in endometrial stroma, but not epithelium, was increased by the embryonic signal interferon-τ (Emond et al. 2000) .
A role for CSF2 in embryonic development is indicated by findings that the addition of CSF2 to the culture medium increased the proportion of in vitro-produced embryos that became blastocysts in culture (de Moraes and Hansen 1997; Loureiro et al. 2009 ). Blastocysts formed in medium containing CSF2 had a tendency for more inner cell mass (ICM) cells and a significantly greater ratio of ICM cells to trophoblast cells (Loureiro et al. 2009 ).
In a recent experiment (Loureiro et al. 2009 ), pregnancy and calving rates for cows receiving embryos treated with CSF2 from Day 5 to Day 7 after insemination was higher (P < 0.05) than for cows receiving control embryos or embryos cultured with insulin-like growth factor (IGF)-1. The pregnancy rate on Days 30-35 for cows receiving CSF2-treated embryos (n = 107) was 43% compared with 34% for cows receiving control embryos (n = 79) and 27% for cows receiving IGF-1-treated embryos (n = 44). The calving rate was 37% for cows receiving CSF2-treated embryos (n = 104), 23% for cows receiving control embryos (n = 74) and 25% for cows receiving IGF-1-treated embryos (n = 44). Note that the loss of pregnancies between Days 30-35 and term tended to be lower for cows receiving embryos cultured with CSF2 (11%) or IGF-1 (8%) than for cows receiving control embryos (22%). This suggests that CSF2 may be producing epigenetic changes in the embryo that exert effects later in gestation to affect fetal survival.
In a second experiment, also reported by Loureiro et al. (2009) , there was no effect of CSF2 treatment on embryo survival on Days 30-35 of pregnancy after transfer, although pregnancy loss after Day 35 was again numerically lower for cows receiving CSF2-treated and IGF-1-treated embryos (Loureiro et al. 2009 ). There are several differences between this experiment and the previous one including lower sample size (e.g. 51 cows receiving CSF2-treated embryos), CSF2 addition at Day 1 after insemination instead of at Day 5, and recipient cows being subjected to heat stress. Further research is required to determine whether the effects of CSF2 are maximised when added later during culture or whether improvements in post-transfer survival do not occur in heat-stressed females.
Insulin-like growth factor-1
Insulin-like growth factor-1 is produced in the bovine oviduct (Pushpakumara et al. 2002) and endometrium (Robinson et al. 2000) and is also likely to enter the reproductive tract from the blood. It is unclear whether the embryo is a source of IGF-1 in the first 7 days of development because some experiments could not detect IGF-1 mRNA (Yaseen et al. 2001; Bertolini et al. 2002) , whereas Lonergan et al. (2000) detected IGF-1 mRNA in early cleaving two-cell embryos and blastocysts. The bovine embryo expresses receptors for IGF-1 as early as the two-cell stage (Wang et al. 2009 ). Moreover, addition of IGF-1 to the culture medium improves the proportion of embryos that develop to the blastocyst stage (for a review, see Block 2007) .
Results from three separate experiments (Block et al. 2003; Block and Hansen 2007; Loureiro et al. 2009 ) conducted in Florida with lactating dairy cows indicate that embryos produced in vitro in the presence of IGF-1 have increased competence for post-transfer survival, but only when recipients are exposed to heat stress (Fig. 1) . The molecular and cellular basis for increased survival of IGF-1-treated blastocysts when placed in heat-stressed recipients is not known. Insulin-like growth factor-1 is a survival factor that protects embryos from a variety of stresses, including heat shock Hansen 2004, 2007) . Nonetheless, treatment with IGF-1 does not simply make embryos resistant to maternal hyperthermia because pregnancy rates achieved with transfer of an IGF-1-treated embryo in the summer can be greater than pregnancy rates in winter (Block and Hansen 2007; Loureiro et al. 2009 ). There was no effect of IGF-1 on the proportion of blastomeres that were apoptotic or on blastocyst cell number (total, ICM or trophectoderm; Block et al. 2008) . Blastocysts produced in the presence of IGF-1 had increased steady state levels of mRNA for desmocollin II and IGF-binding protein 3 and reduced levels of heat shock protein 70 (Block et al. 2008) ; the significance of these changes in gene expression for survival in the summer is not known.
Hyaluronan
The glycosaminoglycan hyaluronan is a component of oviducal and uterine fluids in the cow (Lee and Ax 1984) and its receptor (CD44) is expressed on the preimplantation embryo (Furnus et al. 2003) . The reported effects of the addition of hyaluronan to the culture medium on the proportion of embryos becoming blastocysts are variable, with some authors reporting positive effects (Furnus et al. 1998; Jang et al. 2003; Block et al. 2009 ), some no effect (Lane et al. 2003; Palasz et al. 2008 ) and some reporting effects that depend on the culture medium (Palasz et al. 2006) . Changes in blastocyst gene expression have been reported, including a decrease in steady state levels of mRNA for SOX, involved in oxidative stress, and the pro-apoptotic gene Bax (Palasz et al. 2006 (Palasz et al. , 2008 . Hyaluronan can also enhance blastocyst cryopreservation (Lane et al. 2003; Palasz et al. 2008; Block et al. 2009 ).
A recent experiment by Block et al. (2009) suggests that hyaluronan can improve the competence of less-advanced embryos to establish pregnancy after transfer into recipients. Embryos were produced in vitro in the presence or absence of 1 mg mL −1 hyaluronan and transferred to lactating dairy cows during the summer in Florida. There was an interaction between hyaluronan treatment and stage of embryo transferred on pregnancy rate diagnosed between Days 35 and 90 of gestation (P < 0.05). For cows receiving an expanded blastocyst, there was no difference in pregnancy rate between those receiving an embryo treated with hyaluronan (29.5%; n = 78 cows) and those receiving a control embryo (38.3%; n = 81 cows). However, for cows receiving a morula or non-expanded blastocyst, the pregnancy rate was higher for cows receiving an embryo treated with hyaluronan (28.6%; n = 70 cows) than for cows receiving a control embryo (18.5%; n = 81 cows). Thus, hyaluronan acted to improve the competency of less-developed embryos to a level similar to that of expanded blastocysts.
Gaseous environment
The oxygen content of the atmosphere is an important determinant of blastocyst yield in cattle. The yield of blastocysts is greater when embryos are cultured in 5% (v/v) oxygen than in atmospheric oxygen (20.95% oxygen; Thompson et al. 1990; Lim et al. 1999) . However, it is not clear that blastocysts produced under conditions of low oxygen have higher potential for post-transfer survival. In fact, in the one study in which this question has been examined, the calving rate for cows receiving embryos produced in the presence of low oxygen was 38% (n = 50) compared with 35% (n = 49) for cows receiving embryos produced in atmospheric oxygen (Fischer-Brown et al. 2005) . Calves derived from embryos produced in low oxygen did tend to have lower birthweights than calves derived from embryos produced in atmospheric oxygen (39.7 ± 1.3 v. 43.1 ± 1.4 kg, respectively; P < 0.10).
There may be other aspects of the gaseous environment that affect embryo competence for survival after transfer. Merton et al. (2007) demonstrated that placement of a carbon-activated air-filtration system in the incubator used to culture embryos resulted in blastocysts with improved prospects for establishing pregnancy. There was no effect of the air-filtration system on blastocyst yield, but the pregnancy rate achieved following the transfer of embryos produced with the air-filtration system was higher (P < 0.05) than that following the transfer of embryos produced without the air-filtration system. This was the case for both fresh embryos (46.3% (n = 381) v. 41.0% (n = 401), respectively) and frozen embryos (40.8% (n = 337) v. 35.6% (n = 298), respectively).
Cellular, molecular and biochemical characteristics of embryos with superior potential for post-transfer survival
As apparent from the discussion so far, blastocysts differ in their ability for continued development after transfer to a recipient. Identification of the biological basis for this variation can yield two benefits. First, assays can be developed that allow embryo transfer practitioners to choose embryos for transfer that have the highest probability of establishing a pregnancy. Morphological criteria currently used for this purpose have value in the discrimination of embryo competence for post-transfer survival (Hasler et al. 1995) . However, the approach is imprecise because many embryos with less than optimal morphology also result in pregnancies after transfer and there is significant variation between personnel in classification scores (Farin et al. 1999) . The second benefit is that cellular, molecular and biochemical end-points that predict blastocyst survival after transfer can be used to assess how changes in conditions for the IVP of embryos affect the competence of the resultant blastocysts to establish pregnancies.
A group of genes related to embryonic survival has been identified in an experiment using microarray-based gene profiling (El-Sayed et al. 2006) . Using pools of biopsies from in vitro-produced embryos that were transferred into recipients, 52 genes were identified as being differentially expressed between embryos where pregnancy was established and maintained until term compared with embryos that did not establish pregnancy (i.e. returned to oestrus within 21 days after the preceding oestrus). Of these 52 genes, 46 were downregulated in embryos that maintained pregnancy and six were upregulated. These results suggest the possibility of developing a small gene microarray to screen blastocysts for competence to establish pregnancy. Less-invasive approaches to determining embryo function have also been proposed, although, in most cases, relationship to transfer success has not been established. These approaches included monitoring of embryo secretory proteins (Katz-Jaffe et al. 2009 ), amino acid turnover (Sturmey et al. 2009 ) and caspase-3 activity (Jousan et al. 2008) .
Oxygen consumption may prove useful as an indicator of blastocyst competence for post-transfer survival. Lopes et al. (2007) used a nanorespirometer to measure the oxygen consumption of individual bovine blastocysts. Oxygen consumption increased with increasing morphological quality. Moreover, there was a non-significant tendency for the pregnancy rate to be greater for recipients receiving in vivo-produced embryos with high oxygen consumption (>0.75 nL h −1 ) than for embryos receiving embryos with lower oxygen consumption (<0.75 nL h −1 ). Pregnancy rates were 70% (n = 20 recipients) for heifers receiving embryos with high oxygen consumption compared with 45% (n = 20) for heifers receiving embryos with low oxygen consumption. Further work is needed to confirm this promising observation.
Strategies for additional progress towards producing a superior embryo for transfer
One lesson of this paper is that blastocyst yield does not predict embryo potential for survival after transfer. Thus, although embryo competence for development to the blastocyst stage in vitro can be reduced by the use of sex-sorted spermatozoa for fertilisation (Lu et al. 1999; Wheeler et al. 2006; Wilson et al. 2006; Morton et al. 2007) or by culturing embryos in an atmospheric oxygen environment (Thompson et al. 1990; Lim et al. 1999) , there is little evidence that the transferable embryos formed under these conditions have reduced potential for the establishment and maintenance of pregnancy (FischerBrown et al. 2005; Xu et al. 2006) . Similarly, placement of a carbon-activated air-filtration system in the incubator used to culture embryos resulted in transferable embryos with improved prospects for establishing pregnancy, even though blastocyst yield was unaffected (Merton et al. 2007) .
We are faced with the fact that the best method for determining embryo competence for development after transfer into a healthy calf is to assess pregnancy outcome after transfer. Progress in improvements in embryo production systems that lead to embryos with greater competence for post-transfer survival are difficult because experiments to determine differences in embryo transfer outcomes require large numbers of recipients for adequate power. Assume that there is a real difference in pregnancy rate between embryos of Treatment A and Treatment B of 10 percentage points. Transfer of embryos from Treatment A results in a pregnancy rate of 30%, whereas transfer of embryos from Treatment B results in a pregnancy rate of 40%. If an experiment to detect a difference between these treatments was performed with 300 recipients per group, a significant treatment effect (P < 0.05) would be obtained only 70% of the time (for the Java applet to make calculations of this type, see http://www.cs.uiowa.edu/∼rlenth/Power/, accessed 17 September 2009). Most embryo transfer experiments involve many fewer recipients than 300 per group and therefore it is likely that some real differences between treatments are not seen because of the limited power of the experiment.
It is proposed that three approaches be pursued to improve the potential of the in vitro-produced embryo to establish and maintain pregnancy. The first is to conduct embryo transfer trials with sufficient numbers of recipients to allow meaningful conclusions to be derived. These types of experiments are difficult for many research laboratories because of limited or no access to recipients. Commercial embryo transfer laboratories have this access and partnerships between researchers and embryo transfer practitioners can be an effective way for conducting large-scale and well-designed embryo transfer experiments. The second approach is to develop new procedures for defining molecular and biochemical characteristics of embryos that predict potential for post-transfer survival. Ongoing developments in global assessments of the transcriptome, epigenome, proteome and metabolome create opportunities for more sophisticated and accurate predictors of embryo survival than now possible. Efficient progress in improving IVP systems can be made by combining in vitro assessments of embryo competence to identify promising treatments with follow-up embryo transfer experiments for confirmation of benefit. The third approach is to make effective use of comparisons of embryos produced in vitro with those derived in vivo so as to understand whether changes in culture conditions lead to blastocysts with molecular and cellular characteristics that approach those of the blastocyst that was formed and developed in the reproductive tract.
